WeChat Mini Program
Old Version Features

Immune Features of Ovarian Tumors with a Good Response to Neo-Adjuvant Chemotherapy in Combination with an Anti-Pd-l1 Alone or with an Anti-Ctla4: Data from the Randomized IneOV Trial (a GINECO Study)

JOURNAL OF CLINICAL ONCOLOGY(2023)

Cited 0|Views71
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined